In Q1 2020, UNSW has installed a Magnetic Insight Momentum pre-clinical MPI scanner as the first facility in Australia to provide this novel technology. With its unique set of features MPI supports tracer applications in murine disease models for medical sciences and biology research as well as to the progress of MPI as a new translational imaging modality. The technology is used in various research projects with focus on cell tracking, targeted imaging in cancer and neuroscience, angiogenesis/vascularity quantification as well as in the development of MPI tracer technology to leverage the translational potential of the technology.
Anatomical imaging studies
No nuclear technologies required
Spatial resolution ~1 mm
High tracer sensitivity (detection limits nano-molar trace concentrations)